This is the Age of Evidence.

Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.
our impact
The Age
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
learn more >
2016 Edison Award™ Winner
recognizing excellence in innovation
The Percepta Bronchial Genomic Classifier is improving lung cancer screening and diagnosis.
learn more >
By the Numbers
Through scientific rigor, our tests improve patient outcomes and reduce healthcare costs.

learn more >


latest news
news and updates
Dec 25, 2016
Molecular Diagnostics to Enhance Lung Cancer Screening & Diagnosis

learn more >
Sep 9, 2016
Veracyte Sees Clinical Evidence, Medicare Coverage as Major MDx Success Factors

learn more >
Jan 25, 2016
Tuality’s advanced lung cancer test could lead to the end of biopsies

learn more >